The most frequent fusion transcripts were NTRK3 (54%) and NTRK1 (43%), and only 3% had NTRK2. An ORR of 71% (95% CI 62–79) was observed, independent of tumour type. The gene discussed is NTRK3; the disease is neoplasm.